Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction.
Adoptive T cell immunotherapy is an evolving technology with the potential of providing a means to safely and effectively target tumor cells for destruction.
Ho
William Y
WY
Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Department of Medicine, Seattle, USA.
Blattman
Joseph N
JN
Dossett
Michelle L
ML
Yee
Cassian
C
Greenberg
Philip D
PD
D000818:Animals; D000918:Antibody Specificity; D017951:Antigen Presentation; D002470:Cell Survival; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D008954:Models, Biological; D009369:Neoplasms / Q000628:therapy*; D017434:Protein Structure, Tertiary; D013601:T-Lymphocytes / Q000276:immunology*